Christophe Tribouilloy is an expert in Cardiology at Centre Hospitalier Universitaire Amiens-Picardie (France). As of October 2026, ScienceLeadR ranks Christophe Tribouilloy in the top 1% of experts worldwide for Ventricular Outflow Obstruction, Mitral Valve Insufficiency and Aortic Valve Disease. Christophe Tribouilloy has authored 703 publications, the most recent in 2026, and is an investigator in 14 clinical trials, 2 of them ongoing. SLR score: 2,405 (community average: 125). How the SLR is computed.

LeadR Profile

2 405 ScienceLeadR Reputation 2405
Network Map

Cardiology

Subspecialties: Public Health - Infectiology - Biostatistics

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 1989 - 2026

Source: PubMed

Centre Hospitalier Universitaire Amiens-Picardie

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 703

Citations

Citations: 37 207 1st author: 89 Last author: 201 Unique author: 2


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Late gadolinium enhancement in aortic regurgitation: small scar, big signal?
PMID 42875922 — cicatrix, aortic valve insufficiency
Eur Heart J Cardiovasc Imaging20260
Genetic susceptibility in Takotsubo syndrome: a candidate gene association analysis in the French TAKOGENE cohort.
PMID 42863705 — genes, stress, physiological, genetic predisposition to disease, population control, sex, polymorphism, single nucleotide, genetic diseases, inborn, cardiomyopathies, takotsubo cardiomyopathy
Eur J Med Genet20260
Infective Endocarditis in Solid Organ and Haematopoietic Stem Cell Transplant Recipients (E-IPA Study): a propensity-score-matched retrospective cohort study.
PMID 42624500 — cells, mortality, microscopy, electron, scanning transmission, cohort studies, propensity score, stem cells, endocarditis, transplants, communicable diseases, transplantation
Clin Infect Dis20260
Preprocedural New York Heart Association Class IV Independently Predicts Mortality After Effective Edge-To-Edge Repair for Primary Mitral Regurgitation.
PMID 42491144 — mortality, heart, mitral valve insufficiency
Struct Heart20260
Cardiac magnetic resonance imaging in patients referred for premature ventricular contractions: identifying patients most likely to benefit.
PMID 42459192 — diabetes mellitus, exercise, ventricular premature complexes, fibrosis, magnetic resonance imaging, echocardiography, sex, physical exertion, smoking, cardiomyopathies
Front Cardiovasc Med20260

Clinical Studies 14

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 4

By phase:

N/A 11
Phase 3 2
Phase 4 1

By status:

Recruiting 8
Completed 5
Enrolling by invitation 1

By type:

Observational 8
Interventional 6

By Monocentric/Multicentric:

monocentric 6
multicentric2to4 1
multicentric5to9 0
multicentricup10 7

Main Topics

Cohort/Consortium Investigators 16

Ongoing Clinical Trials

2 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
DIAMOND Study DIrect oral anticoagulant for Antithrombotic Management Of aortic bioprothesis implanted patients for valvular heart Disease Study
2024-516643-64-00 — heart valve diseases, anticoagulants, heart diseases, embolism, heart, thrombosis, direct-acting oral anticoagulants
Phase 3Recruiting2026
Outcome of Patients With Severe Functional TR According to Medical Transcatheter or Surgical Treatment
NCT05825898 — mortality, surgical procedures, operative, hospital mortality, tricuspid valve, therapeutics, tricuspid valve insufficiency
N/AEnrolling by invitation2022

LeadR Networks

Main global connection map